Risk prediction for severe disease and better diagnostic accuracy in early dengue infection; the Colombo dengue study.
Adult
Aspartate Aminotransferases
/ blood
Bayes Theorem
Biomarkers
/ blood
Cohort Studies
Dengue
/ diagnosis
Dengue Virus
/ genetics
Female
Fever
/ virology
Humans
Immunologic Tests
Lymphocyte Count
Male
Middle Aged
Nucleic Acid Amplification Techniques
/ methods
Prospective Studies
Real-Time Polymerase Chain Reaction
/ methods
Risk Assessment
Sensitivity and Specificity
Severe Dengue
/ blood
Sri Lanka
Dengue
Dengue diagnostics
Dengue virus
LAMP
NS1
RT-qPCR
Severe dengue
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
01 Aug 2019
01 Aug 2019
Historique:
received:
19
03
2019
accepted:
22
07
2019
entrez:
3
8
2019
pubmed:
3
8
2019
medline:
8
10
2019
Statut:
epublish
Résumé
A major challenge in dengue management in resource limited settings is the confirmation of diagnosis. Clinical features of dengue often overlap with other infections and molecular diagnostic tools are not readily accessible to clinicians at hospitals. In addition, the prediction of plasma leakage in dengue is also difficult. Hematocrit level and ultrasound scans (combined with clinical parameters) are helpful to detect plasma leakage once it has happened, not before. Colombo Dengue Study (CDS) is a prospective cohort study of clinically suspected adult dengue patients recruited from the National hospital of Sri Lanka (within the first 3 days of fever) that aimed to a) identify clinical and basic laboratory test parameters to differentiate dengue from non-dengue fever, b) evaluate the comparative efficacy of loop-mediated isothermal amplification (LAMP) for dengue diagnosis (vs. NS1 antigen test and RT-qPCR) and c) identify early associations that are predictive of plasma leakage or severe dengue. The basic laboratory tests considered here included hematological parameters, serum biochemistry and inflammatory markers. Only 70% of clinically suspected patients were confirmed as having dengue by either the NS1 antigen test or RT-qPCR. On a Bayesian latent class model which assumes no "gold standard", LAMP performed equally or better than RT-qPCR and NS1 antigen test respectively. When confirmed dengue patients were compared with others, the earlier group had significantly lower lymphocyte counts and higher aspartate aminotransferase levels (AST) within the first 3 days of fever. Confirmed dengue patients with plasma leakage had a lower mean age and a higher median baseline AST level compared to those without plasma leakage (p < 0.05). Clinical suspicion overestimates the true number of dengue patients. RT-LAMP is a potentially useful low-cost diagnostic tool for dengue diagnosis. Confirmed dengue patients had significantly higher AST levels and lower lymphocyte counts in early disease compared to others. In confirmed dengue patients, younger age and a higher AST level in early infection were associated with subsequent plasma leakage.
Sections du résumé
BACKGROUND
BACKGROUND
A major challenge in dengue management in resource limited settings is the confirmation of diagnosis. Clinical features of dengue often overlap with other infections and molecular diagnostic tools are not readily accessible to clinicians at hospitals. In addition, the prediction of plasma leakage in dengue is also difficult. Hematocrit level and ultrasound scans (combined with clinical parameters) are helpful to detect plasma leakage once it has happened, not before.
METHODS
METHODS
Colombo Dengue Study (CDS) is a prospective cohort study of clinically suspected adult dengue patients recruited from the National hospital of Sri Lanka (within the first 3 days of fever) that aimed to a) identify clinical and basic laboratory test parameters to differentiate dengue from non-dengue fever, b) evaluate the comparative efficacy of loop-mediated isothermal amplification (LAMP) for dengue diagnosis (vs. NS1 antigen test and RT-qPCR) and c) identify early associations that are predictive of plasma leakage or severe dengue. The basic laboratory tests considered here included hematological parameters, serum biochemistry and inflammatory markers.
RESULTS
RESULTS
Only 70% of clinically suspected patients were confirmed as having dengue by either the NS1 antigen test or RT-qPCR. On a Bayesian latent class model which assumes no "gold standard", LAMP performed equally or better than RT-qPCR and NS1 antigen test respectively. When confirmed dengue patients were compared with others, the earlier group had significantly lower lymphocyte counts and higher aspartate aminotransferase levels (AST) within the first 3 days of fever. Confirmed dengue patients with plasma leakage had a lower mean age and a higher median baseline AST level compared to those without plasma leakage (p < 0.05).
CONCLUSION
CONCLUSIONS
Clinical suspicion overestimates the true number of dengue patients. RT-LAMP is a potentially useful low-cost diagnostic tool for dengue diagnosis. Confirmed dengue patients had significantly higher AST levels and lower lymphocyte counts in early disease compared to others. In confirmed dengue patients, younger age and a higher AST level in early infection were associated with subsequent plasma leakage.
Identifiants
pubmed: 31370795
doi: 10.1186/s12879-019-4304-9
pii: 10.1186/s12879-019-4304-9
pmc: PMC6676631
doi:
Substances chimiques
Biomarkers
0
Aspartate Aminotransferases
EC 2.6.1.1
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
680Subventions
Organisme : University of Colombo
ID : AP /3/2/2017/CG /25
Organisme : University of Calgary,Canada
ID : -
Références
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Biochem Biophys Res Commun. 2001 Nov 23;289(1):150-4
pubmed: 11708792
Nat Protoc. 2008;3(5):877-82
pubmed: 18451795
J Clin Microbiol. 2008 Nov;46(11):3653-9
pubmed: 18799705
Am J Trop Med Hyg. 2010 Sep;83(3):690-5
pubmed: 20810840
Am J Trop Med Hyg. 2011 Oct;85(4):594-6
pubmed: 21976556
PLoS One. 2012;7(7):e40633
pubmed: 22844405
Infect Drug Resist. 2012;5:103-12
pubmed: 22870039
PLoS Negl Trop Dis. 2012;6(8):e1760
pubmed: 22880140
PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2116
pubmed: 23638191
BMC Infect Dis. 2013 Aug 21;13:387
pubmed: 23964963
Med J Armed Forces India. 2013 Jul;69(3):246-53
pubmed: 24600118
PLoS Negl Trop Dis. 2014 Jul 10;8(7):e2972
pubmed: 25010515
BMC Med. 2014 Sep 04;12:147
pubmed: 25259615
PLoS One. 2015 Sep 18;10(9):e0138694
pubmed: 26384248
Emerg Infect Dis. 2016 Jul;22(7):1295-7
pubmed: 27184629
Open Forum Infect Dis. 2017 May 05;4(2):ofx056
pubmed: 28491893
Front Cell Infect Microbiol. 2017 Jul 12;7:317
pubmed: 28748176
J Med Virol. 2018 May;90(5):803-809
pubmed: 29315684